Synopsis
Synopsis
0
JDMF
0
KDMF
0
VMF
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
Finished Drug Prices
NA
1. Diphosphate, Primaquine
2. Phosphate, Primaquine
3. Primacin
4. Primaquine
5. Primaquine Diphosphate
1. Primaquine Diphosphate
2. 63-45-6
3. Primaquine Bisphosphate
4. Primaquine (diphosphate)
5. Malquine
6. 1,4-pentanediamine, N4-(6-methoxy-8-quinolinyl)-, Phosphate (1:2)
7. Primaquine Phosphate;primaquine Bisphosphate
8. N4-(6-methoxyquinolin-8-yl)pentane-1,4-diamine Bis(phosphate)
9. H0982hf78b
10. Nsc-149765
11. N-(5-aminopentan-2-yl)-6-methoxyquinolin-8-amine; Bis(phosphoric Acid)
12. Primaquine Bis(phosphate)
13. Wr 2975
14. Dsstox_cid_25248
15. Dsstox_rid_80773
16. Dsstox_gsid_45248
17. Ccris 1946
18. Sr-05000001864
19. Ncgc00178754-06
20. Einecs 200-560-8
21. Nsc 149765
22. Primaquine Phosphate [usp]
23. Unii-h0982hf78b
24. Primaquine (tn)
25. Prestwick_406
26. Primaquini Diphosphas
27. Camden
28. Sn13272 Diphosphate
29. 8-((4-amino-1-methylbutyl)amino)-6-methoxyquinoline Diphosphate
30. Cas-63-45-6
31. Ncgc00016284-01
32. 8-((4-amino-1-methylbutyl)amino)-6-methoxyquinoline Phosphate (1:2)
33. Primachine Phosphate
34. Schembl41096
35. Chembl43128
36. Primaquine Bisphosphate, 98%
37. Spectrum1500500
38. Dtxsid6045248
39. Hms502i08
40. Primaquine Phosphate (jan/usp)
41. 8-(4-amino-1-methylbutylamino)-6-methoxyquinoline Diphosphate
42. 8-(4-amino-1-methylbutylamino)-6-methoxyquinolinediphosphate
43. Hms1569o14
44. Hms1920j18
45. Hms2092a19
46. Hms2096o14
47. Hms3652b19
48. Hms3713o14
49. Primaquine Phosphate [jan]
50. Primaquine Diphosphate [mi]
51. Ibscreen-bb Bb_sc-03079
52. Primaquine Phosphate [vandf]
53. Tox21_110350
54. Ccg-40283
55. Mfcd00013166
56. Primaquine Phosphate [mart.]
57. S4237
58. Primaquine Phosphate [usp-rs]
59. Primaquine Phosphate [who-dd]
60. (+-)-8-((4-amino-1-methylbutyl)amino)-6-methoxyquinoline Phosphate (1:2)
61. 1,4-pentanediamine, N(sup 4)-(6-methoxy-8-quinolinyl)-, Phosphate (1:2)
62. Akos026749962
63. Quinoline, 8-((4-amino-1-methylbutyl)amino)-6-methoxy-, Phosphate (1:2)
64. Tox21_110350_1
65. Cs-3875
66. Primaquine Diphosphate [who-ip]
67. 1,4-pentanediamine, N(sup 4)-(6-methoxy-8-quinolinyl)-, (+-)-, Phosphate (1:2)
68. Ncgc00094767-01
69. Ncgc00094767-02
70. As-13148
71. Hy-12651
72. Primaquine Phosphate [orange Book]
73. Db-054488
74. Primaquine Phosphate [usp Monograph]
75. Primaquine Diphosphate [ep Monograph]
76. Primaquini Diphosphas [who-ip Latin]
77. Sw196647-3
78. D02126
79. E75742
80. 013p166
81. Sr-05000001864-1
82. Sr-05000001864-3
83. Sr-05000001864-7
84. Q27279400
85. N4-(6-methoxyquinolin-8-yl)pentane-1,4-diaminebis(phosphate)
86. 8-(4-amino-1-methylbutylamino)-6-methoxyquinoline Diphosphate Salt
87. 1,4-pentanediamine, N^4-(6-methoxy-8-quinolinyl)-, Phosphate (1:2)
88. 8-?(4-?amino-?1-?methylbutylamino)?-?6-?methoxyquinoline Diphosphate Salt
89. Primaquine Diphosphate, European Pharmacopoeia (ep) Reference Standard
90. Primaquine Phosphate, United States Pharmacopeia (usp) Reference Standard
91. Quinoline, 8-((4-amino-1-methylbutyl)amino)-6-methoxy-, Diphosphate
Molecular Weight | 455.34 g/mol |
---|---|
Molecular Formula | C15H27N3O9P2 |
Hydrogen Bond Donor Count | 8 |
Hydrogen Bond Acceptor Count | 12 |
Rotatable Bond Count | 6 |
Exact Mass | 455.12225344 g/mol |
Monoisotopic Mass | 455.12225344 g/mol |
Topological Polar Surface Area | 216 Ų |
Heavy Atom Count | 29 |
Formal Charge | 0 |
Complexity | 312 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
1 of 2 | |
---|---|
Drug Name | Primaquine phosphate |
Drug Label | Primaquine phosphate is 8-[(4-Amino-1-methylbutyl)amino]-6-methoxyquinoline phosphate, a synthetic compound with potent antimalarial activity. Each tablet contains 26.3 mg of Primaquine phosphate (equivalent to 15 mg of primaquine base). The dosage i... |
Active Ingredient | Primaquine phosphate |
Dosage Form | Tablet |
Route | Oral |
Strength | eq 15mg base |
Market Status | Prescription |
Company | Bayshore Pharms; Alvogen |
2 of 2 | |
---|---|
Drug Name | Primaquine phosphate |
Drug Label | Primaquine phosphate is 8-[(4-Amino-1-methylbutyl)amino]-6-methoxyquinoline phosphate, a synthetic compound with potent antimalarial activity. Each tablet contains 26.3 mg of Primaquine phosphate (equivalent to 15 mg of primaquine base). The dosage i... |
Active Ingredient | Primaquine phosphate |
Dosage Form | Tablet |
Route | Oral |
Strength | eq 15mg base |
Market Status | Prescription |
Company | Bayshore Pharms; Alvogen |
Antimalarials
Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) (See all compounds classified as Antimalarials.)
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?